Table 1 Clinicopathological characteristics of the study population
Variable | n of patients (%) |
|---|---|
Age | |
  ≤ 56 | 78(49.7%) |
  > 56 | 79(50.3%) |
Gender | |
 male | 142(90.4%) |
 female | 15(9.6%) |
HBsAg | |
 negative | 28(17.8%) |
 positive | 129(82.2%) |
HCV-Ab | |
 negative | 152(96.8%) |
 positive | 5(3.2%) |
AFP | |
  ≤ 20 | 60(38.2%) |
  > 20 | 97(61.8%) |
ALT | |
  ≤ 40 | 126(80.3%) |
  > 40 | 31(19.7%) |
γ-GT | |
  ≤ 50 | 96(61.1%) |
  > 50 | 61(38.9%) |
Liver cirrhosis | |
 no | 34(21.7%) |
 yes | 123(78.3%) |
Child-Pugh score | |
 A | 151(96.2%) |
 B | 6(3.8%) |
Tumor differentiation | |
 I–II | 93(59.2%) |
 III–IV | 64(40.8%) |
Tumor size, cm | |
  ≤ 5 | 107(68.2%) |
  > 5 | 50(31.8%) |
Tumor number | |
 single | 98(62.4%) |
 multiple | 59(37.6%) |
Tumor encapsulation | |
 complete | 72(45.9%) |
 none | 85(54.1%) |
Vascular invasion | |
 no | 112(71.3%) |
 yes | 45(28.7%) |
BCLC stage | |
 0-A | 99(63.1%) |
 B-C | 58(36.9%) |
Lung metastasis | |
 no | 134(85.4%) |
 yes | 23(14.6%) |
Lymph node metastasis | |
 no | 137(87.3%) |
 yes | 20(12.7%) |
Bone metastasis | |
 no | 139(88.5%) |
 yes | 18(11.5%) |
Lnc34a | |
 low | 77(49.0%) |
 high | 80(51.0%) |